8-K
Table of Contents

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 22, 2004

RESPIRONICS, INC.

(Exact name of Registrant as specified in its charter)
         
Delaware   000-16723   25-1304989
  		 
  		 
 
(State or Other
Jurisdiction of
Incorporation) 		  (Commission File
Number) 		  (I.R.S. Employer
Identification
Number)
 



1010 Murry Ridge Lane
Murrysville, Pennsylvania 		     



15668-8525
  		     
 
(Address of Principal
Executive Offices) 		      (Zip Code)

724-387-5200

(Registrant’s telephone number, including area code)

TABLE OF CONTENTS

         
    Page
    2  
    3  
    4  
 Exhibit 99

 

Table of Contents

Item 12. DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

     On July 22, 2004, Respironics Inc. issued a press release announcing its financial results for the three months and fiscal year ended June 30, 2004. A copy of the press release is attached hereto as Exhibit 99.

Exhibits

     
99
  Press release, dated July 22, 2004, issued by Respironics, Inc.

2

Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
  RESPIRONICS, INC.
 		  
  By:   /s/ Daniel J. Bevevino    
    Daniel J. Bevevino   
    Vice President, and Chief Financial and Principal Accounting Officer   
 

Dated: July 22, 2004

3

Table of Contents

INDEX TO EXHIBITS

     
Exhibit No.
   Description
99   Press release, dated July 22, 2004, issued by Respironics, Inc.

4